Search

Your search keyword '"Erez N"' showing total 943 results

Search Constraints

Start Over You searched for: Author "Erez N" Remove constraint Author: "Erez N"
943 results on '"Erez N"'

Search Results

2. An Asymmetric Sparse Telescope

3. Optical amplification for astronomical imaging at higher resolution

4. Phasing a deployable sparse telescope

5. Capture of free-floating planets by stellar systems

8. Beyond the diffraction limit via optical amplification

10. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

11. Enhancing retinal images by nonlinear registration

12. Spectroscopic identification of habitable extra-solar planets

13. Fainter and closer: finding planets by symmetry breaking

14. Path-phase duality of an interfering particle with translational-internal entanglement

15. MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

16. Off-Line, Multi-Detector Intensity Interferometers I: Theory

17. Off-Line, Multi-Detector Intensity Interferometers II: Implications and Applications

18. Another Look at Quantum Teleportation

21. Supplementary Figure 8 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

22. Supplementary Figure 3 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

23. Supplementary Figure 2 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

24. Supplementary Figure 5 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

25. Supplementary Figure 4 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

26. Supplementary Figure 1 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

28. Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells

29. Table S4 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

30. Supplementary Figure Legends from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

31. Data from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

32. Supplementary Figure 6 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

33. Supplementary Figure 7 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

34. Mesenchymal Stem/Stromal Cells: BIOLOGICAL THREAT AGENT RICIN INTOXICATION OF THE LUNGS IS EFFECTIVELY TREATED BY MESENCURE, A PROFESSIONALIZED ALLOGENEIC MESENCHYMAL CELL THERAPY, PREFERABLY VIA THE SUBCUTANEOUS ROUTE

35. MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

36. Data from Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells

37. Supplementary Table from Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells

38. Supplementary Figure from Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells

39. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.

40. Table S3 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

45. Data from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

Catalog

Books, media, physical & digital resources